Cutting-edge nanotechnologies and biomaterials demonstrate transformative potential in therapeutic delivery and oncology. Soft neural interfaces paired with wireless micropumps enable controlled, implantable drug administration, advancing bioelectronic medicine. Graphene quantum dot nanocomposites represent a novel glioblastoma treatment strategy, leveraging unique delivery and targeting capabilities. Self-assembling polymer nanoparticles forming at room temperature offer scalable platforms conducive to sensitive protein and siRNA biologics delivery. Concurrently, sericin-silver nanoparticle conjugates exhibit potent colorectal cancer activity, exemplifying natural product integration with nanotechnology for precision therapeutics.